Mediated and unmediated influence of pathological factors on ovarian reserve (а review)

Close metadata

Recommended articles:

Profile of serum autoantibodies in women with premature ovarian insufficiency receiving complex treatment using new surgical technologies. Russian Journal of Human Reproduction. 2024;(2):32-41

Breast pathology in the practice of gynaecologist of children and adolescents (own data). Russian Journal of Human Reproduction. 2024;(3):23-32

Innovative approaches to the formation of reproductive behavior and health of young people at the regional level. Russian Journal of Human Reproduction. 2024;(4):6-11

Dynamics of the condition of patients with premature ovarian insufficiency and the autoantibody profile before and after the use of new surgical technologies in complex treatment. Russian Journal of Human Reproduction. 2024;(5):25-34

Reproductive aspects in the treatment of colorectal endometriosis. Russian Journal of Human Reproduction. 2024;(6):140-148

Gonadotropin-releasing hormone agonists as a chance for motherhood in the future. Russian Bulletin of Obstetrician-Gynecologist. 2024;(2):30-36

Predicting the risk of decreased ovarian reserve after surgical treatment of patients with deep infiltrative endometriosis using artificial intelligence. Russian Bulletin of Obstetrician-Gynecologist. 2024;(3):92-102

The literature review focuses on ovarian reserve, the definition available in modern domestic and foreign literature. The physiological and pathophysiological factors are described and discussed. The study of the damaging factors can help to form risk groups and plan to further their reproductive behavior.

Keywords:

ovarian reserve

physiological factors

pathological factors

reproductive health

Authors:

Gasymova D.M.

I.I. Dzhanelidze Saint Petersburg Research Institute of Emergence Care, Saint Petersburg, Russia

Rukhliada N.N.

Sankt-Peterburgskiĭ NII skoroĭ pomoshchi im. I.I. Dzhanelidze

SPIN RSCI: 4851-0283
Scopus AuthorID: 57191912761
ORCID: 0000-0002-3548-0468

List of references:

Testing and interpreting measures of ovarian reserve: a committee opinion. Practice committee of the American society for reproductive medicine. Fertil Steril. 2015;103(3):9-17. https://doi.org/10.1016/j.fertnstet.2014.12.093
Committee opinion no. 618: ovarian reserve testing. Obstet Gynecol. 2015;125(1):268-273. https://doi.org/10.1097/01.AOG.0000459864.68372.ec
Deng J, Jia M, Cheng X, Yan Z, Fan D, Tian X. AB0 blood group and ovarian reserve: a meta-analysis and systematic review. Oncotarget. 2017;8(15):25628-25636. https://doi.org/10.18632/oncotarget.15759
Denisenko MV, Kurtser MA, Kurilo LF. Ovarian reserve and methods of its evaluation. Voprosy ginekologii, akusherstva i perinatologii. 2016;15(3):41-47. (In Russ.)
Kavteladze EV, Solomatina AA, Safronova DA, Smirnova AA, Tyumentseva MYu. Ovarian reserve and functional state of the ovaries in endometriosis before and after surgery. Vestnik Rossiiskogo gosudarstvennogo meditsinskogo universiteta. 2011;2:73-77. (In Russ.)
Gasparov AS, Dubinskaya ED, Titov DS. The clinical significance of ovarian reserve in the implementation of reproductive function. Akusherstvo i ginekologiya. 2014;4:11-16. (In Russ.)
Findlay JK, Hutt KJ, Hickey M, Anderson RA. What is the «ovarian reserve»? Fertil Steril. 2015;103(3):628-630. https://doi.org/10.1016/j.fertnstert.2014.10.037
Boyarskii KYu, Gaidukov SN. Determinants of ovarian reserve women. Zhurnal akusherstva i zhenskikh boleznei. 2009;2:65-71. (In Russ.)
Shcherbina NA, Gradil’ OG. Assessment of age-related changes of the ovarian reserve in women with infertility. Tavricheskii mediko-biologicheskii vestnik. 2013;16(2):140-144. (In Russ.)
Gleicher N, Kim A, Weghofer A. Toward a better understanding of functional ovarian reserve: AMH (AMHo) and FSH (FSHo) hormone ratios per retrieved oocyte. J Clin Endocrinol Metab. 2012;97(3):995-1004. https://doi.org/10.1210/jc.2011-2403
Ramalho de Carvalho B, Gomes Sobrinho DB, Vieira AD, Resende MP, Barbosa AC, Silva AA, Nakagava HM. Ovarian reserve assessment for infertility investigation. ISRN Obstet Gynecol. 2012;2012:576385. https://doi.org/10.5402/2012/576385
Fleming R, Seifer DB, Frattarelli JL, Ruman J. Assessing ovarian response: antral follicle count versus anti-müllerian hormone. Reprod Biomed Online. 2015;31(4):486-496. https://doi.org/10.1016/j.rbmo.2015.06.015
Kel’manson IA. Perinatologiya i perinatal’naya psikhologiya. SPb.: SpetsLit. 2015. (In Russ.)
Nazarenko TA, Krasnopol’skaya KV. «Bednyi otvet». Taktika vedeniya patsientok so snizhennoi reaktsiei na stimulyatsiyu gonadotropinami v programmakh EKO. M.: MEDpressinform. 2013. (In Russ.)
Ovarial’nyi rezerv i fertil’nost’: slozhnosti XXI veka. Ratsional’nyi podkhod k sokhraneniyu reproduktivnogo rezerva kak zalog fertil’nosti i osoznannogo detorozhdeniya. Informatsionnoe pis’mo. Pod red. Radzinskogo VE. M.: Redaktsiya zhurnala Status Praesens. 2015. (In Russ.)
Amanvermez R, Tosun M. An update on ovarian aging and ovarian reserve tests. Int J Fertil Steril. 2016;9(4):411-415. https://doi.org/10.22074/ijfs2015.4591
Jirge PR. Poor ovarian reserve. J Hum Reprod Sci. 2016;9(2):63-69. https://doi.org/10.4103/0974-1208.183514
Mutlu MF, Erdem A. Evaluation of ovarian reserve in infertile patients. J Turk Ger Gynecol Assoc. 2012;3(13):196-203. https://doi.org/10.5152/jtdda.2012.28. eCollection 2012
Mutlu MF, Erdem M, Erdem A. Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles. J Assist Reprod Genet. 2013;30(5):657-665. https://doi.org/10.1007/s10815-013-9975-3
Hewlett M, Mahalingaiah S. Update on primary ovarian insufficiency. Curr Opin Endocrinol Diabetes Obes. 2015;22(6):483-489. https://doi.org/10.1097/MED.0000000000000206
Barasoain M, Barrenetxea G, Huerta I, Télez M, Criado B, Arrieta I. Study of the genetic etiology of primary ovarian insufficiency: FMR1 Gene. Genes (Basel). 2016;7(12);pii: E123. https://doi.org/10.3390/genes7120123
Cox L, Liu JH. Primary ovarian insufficiency: an update. Int J Womens Health. 2014;6:235. https://doi.org/10.2147/IJWH.S37636
Iwase A, Nakamura T, Nakahara T, Goto M, Kikkawa F. Assessment of ovarian reserve using anti-Müllerian hormone levels in benign gynecologic conditions and surgical interventions: a systematic narrative review. Reprod Biol Endocrinol. 2014;12:125. https://doi.org/10.1186/1477-7827-12-125
Savchenko TN, Khashukoeva AZ, Il’ina IYu, Narimanova MR, Agaeva MI, Dergacheva IA. Inflammatory diseases of the pelvic organs: impact on the reproductive health of women, the prospects of treatment. Lechashchii vrach. 2014;12:8-11. (In Russ.)
Gur’eva VA, Kurakina VA. Assessment of determinants of ovarian reserve in women with impaired reproductive function. Zhurnal akusherstva i zhenskikh boleznei. 2012;61(6):76-81. (In Russ.)
Erenkova SE, Beisembaeva MK, Murtaeva DA, Nurmambetova DA, Gusenova RI, Kemelbekova AA, Dauletbaeva ZhB, Mirzakhmetova NKh. The condition of the ovaries after surgical interventions on the pelvic organs in women of reproductive age. Vestnik KazNMU. 2014;3(3):65-68. (In Russ.)
Kupriyanova II, Petrov IA, Tikhonovskaya OA. The status of the ovarian reserve after surgery on the fallopian tubes. Sovremennye problemy nauki i obrazovaniya. 2015;6:71-76. (In Russ.)
Gasymova UR, Sosnova EA, Grachev GA. The effects of surgical interventions on the pelvic organs in women of reproductive age. Problemy zhenskogo zdorov’ya. 2012;7(3):56-60. (In Russ.)
Ye X, Yang Y, Sun X. A retrospective analysis of the effect of salpingectomy on serum anti-müllerian hormone level and ovarian reserve. Am J Obstet Gynecol. 2015;212:53.e1-e10. https://doi.org/10.1016/j.ajog.2014.07.027
Grynnerup AG, Lindhard A, Sørensen S. Anti-müllerian hormone levels in salpingectomized compared with nonsalpingectomized women with tubal factor infertility and women with unexplained infertility. Acta Obstet Gynecol Scand. 2013;92:1297-1303. https://doi.org/10.1111/aogs.12234
Ganer Herman H, Gluck O, Keidar R, Kerner R, Kovo M, Levran D, Bar J, Sagiv R. Ovarian reserve following cesarean section with salpingectomy vs tubal ligation: a randomized trial. Am J Obstet Gynecol. 2017;pii:S0002-9378(17)30557-4. https://doi.org/10.1016/j.ajog.2017.04.028
Venturella R, Morelli M, Lico D, Di Cello A, Rocca M, Sacchinelli A. Wide excision of soft tissues adjacent to the ovary and fallopian tube does not impair the ovarian reserve in women undergoing prophylactic bilateral salpingectomy: results from a randomized, controlled trial. Fertil Steril. 2015;104:1332-1339. https://doi.org/10.1016/j.fertnstert.2015.08.004
Macer ML, Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am. 2012;39(4):535-549. https://doi.org/10.1016/j.ogc.2012.10.002
Marzhevskaya AM, Rishchuk SV, Gusev SN, Tatarova NA. Reproduktivnye narusheniya u bol’nykh endometriozom: etiologiya, patogenez, vozmozhnosti korrektsii. Byulleten’ Orenburgskogo nauchnogo tsentra UrO RAN (elektronnyi zhurnal). 2014;3:1-42. (In Russ.) https:// www.elmag.uran.ru
Johnson NP. Lone hummelshoj for the World endometriosis society montpellier consortium. Hum Reprod. 2013 March 25.
González-Comadran M, Schwarze JE, Zegers-Hochschild F, Souza MD, Carreras R, Checa MA. The impact of endometriosis on the outcome of assisted reproductive technology. Reprod Biol Endocrinol. 2017;15(1):8. https://doi.org/10.1186/s12958-016-0217-2
Ailamazyan EK, Tolibova GKh, Tral’ TG, Kogan IYu. Features of the expression of the receptors of sex steroid hormones, inflammatory markers and inhibitor of the cyclin-dependent kinase p16ink4a in the endometrium with external genital endometriosis. Zhurnal akusherstva i zhenskikh boleznei. 2016;64(6):4-11. (In Russ.)
Hawkins Bressler L, Bernardi LA, De Chavez PJ, Baird DD, Carnethon MR, Marsh EE. Alcohol, cigarette smoking, and ovarian reserve in reproductive-age African-American women. Am J Obstet Gynecol. 2016;215(6):758.e1-758.e9. https://doi.org/10.1016/j.ajog.2016.07.012
Fuentes A, Munoz A, Pommer R, Arguello B, Galleguillos A, Torres A, Jesam C. Decreased anti-müllerian hormone concentration in follicular fluid of female smokers undergoing artificial reproductive techniques. Chemosphere. 2012;88(4):403-406. https://doi.org/10.1016/j. chemosphere.2012.02.054
Fuentes A, Escalona J, Céspedes P, Repetto V, Iñiguez G. Effects of smoking on plasma antimüllerian hormone concentrations among infertile women. Rev Med Chil. 2013;141(1):23-27. https://doi.org/10.4067/S0034-98872013000100003
Bentzen JG, Forman JL, Pinborg A, Lidegaard Ø, Larsen EC, Friis-Hansen L, Johannsen TH, Nyboe Anderson A. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. Reprod Biomed Online. 2012;25:612-619. https://doi.org/10.1016/j.rbmo.2012.09.001
Dolleman M, Verschuren WM, Eijkemans MJ, Dolle ME, Jansen EH, Broekmans FJ, van der Schouw YT. Reproductive and lifestyle determinants of anti-Mullerian hormone in a large population-based study. J Clin Endocrinol Metab. 2013;98:2106-2115. https://doi.org/10.1210/jc.2012-3995
Wise LA, Troisi R, Hatch EE, Titus LJ, Rothman KJ, Harlow BL. Prenatal diethylstilbestrol exposure and reproductive hormones in premenopausal. J Dev Orig Health Dis. 2015;3(6):208-216. https://doi.org/10.1017/S2040174415000082
Iwase A, Nakamura T, Nakahara T, Goto M, Kikkawa F. Anti-müllerian hormone and assessment of ovarian reserve after ovarian toxic treatment: a systematic narrative review. Reprod Sci. 2015;22:519-526. https://doi.org/10.1177/1933719114549856
Behringer K, Mueller H, Goergen H, Thielen I, Eibl AD, Stumpf V, Wessels C, Wiehlputz M, Rosenbrock J, Halbsguth T, Reiners KS, Schober T, Renno JH, von Wolf M, van der Ven K, Kuehr M, Fuchs M, Diehl V, Engert A, Borchmann P. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. J Clin Oncol. 2013;31:231-239. https://doi.org/10.1200/JCO.2012.44.3721
Kokaeva LE, Troik EB, Sergeeva IV, Shneider TV. Reproductive health in patients with Hodgkin’s lymphoma. SISP. 2012;9(17):92. (In Russ.)
Behringer K, Thielen I, Mueller H, Goergen H, Eibl AD, Rosenbrock J, Halbsguth T, Eichenauer DA, Fuchs M, Reiners KS, Renno JH, van der Ven K, Kuehr M, von Wolff M, Diehl V, Engert A, Borchmann P. Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. Ann Oncol. 2012;23(7):1818-1825. https://doi.org/10.1093/annonc/mdr575

Close metadata